Leading researchers bolster Copenhagen’s life science cluster
14 2月 2013
University of Copenhagen will soon be home to two top life science research teams, following two leading biotech professors each receiving a Euro 5.4 million grant from the Novo Nordisk Foundation. Copenhagen’s strong life science cluster is an influential factor in making Copenhagen an attractive research destination, the professors say.
Two Euro 5.4 million Laureate Research Grants from the Novo Nordisk Foundation have secured the homecoming of Denmark’s internationally acknowledged researcher Kenn Gerdes, who will return to University of Copenhagen from Newcastle University. He will be accompanied by the Canadian Professor Stephen M. Cohen from National University of Singapore.
-The University of Copenhagen and other universities in the area host some of the world's leading research teams within the field of major pathogenic bacteria. Moreover, Copenhagen and Southern Sweden is home to one of Europe's strongest life science clusters. In combination with the Laureate Research Grant’s unique long-term funding opportunity, these reasons were crucial to my decision to move to Copenhagen, says Kenn Gerdes in a press release.
-The presence of world class professors like Kenn Gerdes and Stephen Cohen is a gain for the Copenhagen life science cluster. They take the R&D environment to a new level, making it attractive for other highly skilled researchers to conduct their research here. That is why Copenhagen Capacity works to attract and retain top researchers in the Copenhagen Region, says Nikolaj Lubanski, Talent Director, Copenhagen Capacity.
Kenn Gerdes holds a Ph.D. in molecular genetics from the Technical University of Denmark. Specialising in bacteria persistence, Gerdes will conduct research in new methods to fight recurrent and chronic infections.
Cohen’s research in Denmark will primarily focus on micro RNA in cancer. His research aims to uncover how different genes co-behave during cancer and metastasis development and to identify new bio markers for diagnostics.
The two researchers have each received a Euro 5.4 million grant, which is the largest sum the Novo Nordisk Foundation has ever granted any single researcher. According to the Novo Nordisk Foundation, the two research teams will be fully up and running in 2015 and the research funding runs for seven years.
This is an excerpt. Read the full article (IN DANISH) here